| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 796.603 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 838.004 | 95 |
| GSM780709 | Untreated after 4 days (C3_1) | 820.809 | 95 |
| GSM780719 | Untreated after 4 days (C1_2) | 866.648 | 95 |
| GSM780720 | Untreated after 4 days (C2_2) | 747.812 | 94 |
| GSM780721 | Untreated after 4 days (C3_2) | 825.038 | 95 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 877.297 | 95 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 805.247 | 95 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 803.842 | 94 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 727.632 | 94 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 791.077 | 94 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 769.069 | 94 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 987.266 | 95 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 779.159 | 94 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 825.838 | 95 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 789.038 | 94 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 788.779 | 94 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 745.317 | 94 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 789.038 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 845.932 | 95 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 817.947 | 95 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 700.515 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 737.942 | 94 |